Epidemiology of Violence
We will start by describing the method of transmission, exploring the ways in which people are exposed to violence, the effects of different kinds of exposure, and modulating factors such as age, dose, and immunity. We will also look at the physiological effects of violence, particularly neurological effects including the process of modeling, the role of mirror neurons, desensitization, hyper-arousal, dissociative reactions, and other effects. We will then describe the natural history of violence as a disease and describe the pathogenesis of violence, including susceptibility, latency, incubation, and the possible clinical courses based on exposure. To the extent that they are available, we will discuss levels of risk based on exposure for different types of violence, including child abuse, war violence, religious and ethnic violence, and community violence.
We will conclude with a discussion of the implications for this understanding of violence, including strategies for addressing violence as a disease. This discussion will include roles for health professionals in how to detect and treat persons exposed to violence and steps for communities to take to treat violence as a disease, and examples of current health approaches that treat violence like a disease.
Learning Areas:Chronic disease management and prevention
Public health or related research
Social and behavioral sciences
Describe the physiological effects of exposure to violence. List the possible clinical courses of violence as a disease. Describe a method to treat violence like a disease.
Keyword(s): Youth Violence, Epidemiology
Qualified on the content I am responsible for because: I am the director of Research and Evaluation for Cure Violence, which uses a health and epidemic control approach to reducing community violence.
Any relevant financial relationships? Yes
|Name of Organization||Clinical/Research Area||Type of relationship|
|Cure Violence||Violence Prevention||Employment (includes retainer)|
I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.